InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,482.68
(
0.33%
)
US TECH 100
19,118.80
(
-0.46%
)
Dow Jones
39,497.37
(
0.89%
)
Brent Oil
85.19
(
1.39%
)
Bitcoin
60,760.49
(
-3.81%
)
Post# of 252317
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Summer2762

Send PM Follow Ignore
Followers 7
Posts 193
Boards Moderated 0
Alias Born 10/26/2011

Summer2762

Re: mcbio post# 148105

Monday, 09/03/2012 2:39:58 PM

Monday, September 03, 2012 2:39:58 PM

Post# of 252317
I havent heard of this portfolio review before. All I could find about it was the following quote in the latest CC.

We are currently undergoing a very detailed review of every project that's part of the R&D portfolio. DiaPep is part of that, and we will be reporting on the outcome of all of this during our Investor Day in December.



Do you have more info about this?

Anyway, I dont believe they would cut it just before the SYNERGY's interim analysis. They would look really stupid if the interim crosses the boundary. If they have any intention to do so, they would wait few more months for the interim and then announce it.

I agree, if they do, that will be a major opportunity to invest in OGXI.

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up